Jane Yardley

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study

Martin R. Farlow, Stephen Salloway, Pierre N. Tariot et al. · Clinical Therapeutics · 2010 · 212 citations

Alzheimer's Disease, Psychiatry, Medicine +8

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2

Mikko Kärppä, Jane Yardley, Kate Pinner et al. · SLEEP · 2020 · 156 citations · Full text

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

Martin R. Farlow, Felix Veloso, Margaret Moline et al. · BMC Neurology · 2011 · 94 citations · Full text

Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial

Jane Yardley, Mikko Kärppä, Yuichi Inoue et al. · Sleep Medicine · 2021 · 82 citations · Full text

Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials

Margaret Moline, Gary Zammit, Jane Yardley et al. · Postgraduate Medicine · 2020 · 43 citations